| Interleukin-2 and regulatory T cells in graft-versus-host disease J Koreth, K Matsuoka, HT Kim, SM McDonough, B Bindra, EP Alyea III, ... New England Journal of Medicine 365 (22), 2055-2066, 2011 | 1241 | 2011 |
| Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients FS Hodi, MC Mihm, RJ Soiffer, FG Haluska, M Butler, MV Seiden, T Davis, ... Proceedings of the National Academy of sciences 100 (8), 4712-4717, 2003 | 1208 | 2003 |
| Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials J Koreth, R Schlenk, KJ Kopecky, S Honda, J Sierra, BJ Djulbegovic, ... Jama 301 (22), 2349-2361, 2009 | 1106 | 2009 |
| IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo E Zorn, EA Nelson, M Mohseni, F Porcheray, H Kim, D Litsa, R Bellucci, ... Blood 108 (5), 1571-1579, 2006 | 927 | 2006 |
| Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation P Armand, HT Kim, BR Logan, Z Wang, EP Alyea, ME Kalaycio, ... Blood, The Journal of the American Society of Hematology 123 (23), 3664-3671, 2014 | 855 | 2014 |
| Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in … R Soiffer, T Lynch, M Mihm, K Jung, C Rhuda, JC Schmollinger, FS Hodi, ... Proceedings of the National Academy of Sciences 95 (22), 13141-13146, 1998 | 733 | 1998 |
| Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome JA Coppell, PG Richardson, R Soiffer, PL Martin, NA Kernan, A Chen, ... Biology of blood and marrow transplantation 16 (2), 157-168, 2010 | 671 | 2010 |
| Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis M Eapen, V Rocha, G Sanz, A Scaradavou, MJ Zhang, W Arcese, ... The lancet oncology 11 (7), 653-660, 2010 | 654 | 2010 |
| The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation VT Ho, RJ Soiffer Blood, The Journal of the American Society of Hematology 98 (12), 3192-3204, 2001 | 582 | 2001 |
| Ipilimumab for patients with relapse after allogeneic transplantation MS Davids, HT Kim, P Bachireddy, C Costello, R Liguori, A Savell, ... New England Journal of Medicine 375 (2), 143-153, 2016 | 578 | 2016 |
| Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease E Zorn, HT Kim, SJ Lee, BH Floyd, D Litsa, S Arumugarajah, R Bellucci, ... Blood 106 (8), 2903-2911, 2005 | 570 | 2005 |
| Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation P Armand, HT Kim, CS Cutler, VT Ho, J Koreth, EP Alyea, RJ Soiffer, ... Blood 109 (10), 4586-4588, 2007 | 541 | 2007 |
| Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease K Matsuoka, J Koreth, HT Kim, G Bascug, S McDonough, Y Kawano, ... Science translational medicine 5 (179), 179ra43-179ra43, 2013 | 521 | 2013 |
| Rituximab for steroid-refractory chronic graft-versus-host disease C Cutler, D Miklos, HT Kim, N Treister, SB Woo, D Bienfang, LB Klickstein, ... Blood 108 (2), 756-762, 2006 | 513 | 2006 |
| Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation VT Ho, C Cutler, S Carter, P Martin, R Adams, M Horowitz, J Ferrara, ... Biology of blood and marrow transplantation 11 (8), 571-575, 2005 | 500 | 2005 |
| Antibody responses to HY minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission DB Miklos, HT Kim, KH Miller, L Guo, E Zorn, SJ Lee, EP Hochberg, ... Blood 105 (7), 2973-2978, 2005 | 493 | 2005 |
| Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases TJ Henrich, E Hanhauser, FM Marty, MN Sirignano, S Keating, TH Lee, ... Annals of internal medicine 161 (5), 319-327, 2014 | 485 | 2014 |
| Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation R Bejar, KE Stevenson, B Caughey, RC Lindsley, BG Mar, P Stojanov, ... Journal of clinical oncology 32 (25), 2691, 2014 | 459 | 2014 |
| Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. MJ Robertson, RJ Soiffer, SF Wolf, TJ Manley, C Donahue, D Young, ... The Journal of experimental medicine 175 (3), 779-788, 1992 | 451 | 1992 |
| Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations S Giralt, L Costa, J Schriber, J DiPersio, R Maziarz, J McCarty, ... Biology of Blood and Marrow Transplantation 20 (3), 295-308, 2014 | 445 | 2014 |
